4 days ago
Citi upgrades Fisher & Paykel Healthcare Corporation Limited (FSPKF) to a Hold
Fisher & Paykel Healthcare Corporation Limited (FSPKF – Research Report) received a Hold rating and price target from Citi analyst Mathieu Chevrier today. The company's shares closed last Thursday at $20.70.
Confident Investing Starts Here:
According to TipRanks, Chevrier is an analyst with an average return of -5.4% and a 40.30% success rate. Chevrier covers the Healthcare sector, focusing on stocks such as Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per Cochlear , and EBOS Group Limited.
In addition to Citi, Fisher & Paykel Healthcare Corporation Limited also received a Hold from UBS's Marcus Curley in a report issued on May 29. However, on May 30, Morgan Stanley upgraded Fisher & Paykel Healthcare Corporation Limited (Other OTC: FSPKF) to a Buy.
Based on Fisher & Paykel Healthcare Corporation Limited's latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $951.2 million and a net profit of $153.2 million. In comparison, last year the company earned a revenue of $815.8 million and had a net profit of $107.3 million
